The global anesthesia drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). The increase in the number of surgeries and approvals of new anesthetic drugs are the main drivers of the market. According to data published by the International Society for Aesthetic Plastic Surgery, the number of plastic procedures performed worldwide increased by 7.4% in 2019 compared to the previous year (2018). This shows an increase in the number of procedures, which leads to an increase in the demand for anesthetic drugs.
To request an example from our report on the global anesthesia drug market : https://www.omrglobal.com/request-sample/anesthetic-medicines-market
In addition, the United Nations Department of Economics and Welfare estimates that one in four people in Europe and North America will be 65 or older by 2050. The increase in the elderly population has resulted in a sharp increase in the number of chronic diseases among the elderly, such as cardiovascular and neurological diseases, increasing the demand for anesthetic drugs. Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a drug for sedation of non-intubated patients before and/or during surgery and other surgeries, was immediately launched by Fresenius Kabi in June 2019. Medova and the New York Regional School of Anesthesiology (NYSORA) announced a collaboration in June 2020 To bring SAFIRA (SAFer Injection for Regional Anesthesia) to the USA. In addition,
Furthermore, the increased number of surgeries, an older population with more chronic diseases, and advancements in anesthesia technologies support driving the market. According to the American Society of Plastic Surgeons (ASPS), in the United States in 2019, approximately 1.8 million cosmetic surgical operations and 16.3 million minimally invasive cosmetic procedures were performed. The demand for different anesthetics is directly proportional to the surgical procedures being performed. The use of anesthetics in general operations is expected to have a substantial impact on market growth.
Market coverage
- The available market number for – 2020-2027
- Base year – 2020
- Forecast period- 2021-2027
- segment covered
- Areas covered – Global
Competitive landscape: Baxter International Inc., Pfizer Inc., GlaxoSmithKline (GSK), Merck & Co., Inc., ו-Aurobindo Pharma Ltd., בין היתר.
A complete report of the global anesthesia drugs market readily available at https://www.omrglobal.com/industry-reports/anesthetic-medicines-market
Global anesthesia drug market – segmentation
according to the type of drug
- Drugs for general anesthesia
- local anesthetic drugs
by application
- General analysis
- Cosmetic surgeries
- plastic surgery
- Dental surgeries
- other applications
The global anesthesia drug market – segmentation by region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- rest of Europe
Asia Pacific
- India
- porcelain
- Japan
- South Korea
- Rest of APAC
the rest of the world
Reasons to buy from us –
- We cover more than 15 major industries, segmented into more than 90 sectors.
- More than 120 countries are targeted for analysis.
- Over 100 paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For more customized data, request a report customization @ https://www.omrglobal.com/report-customization/anesthetic-medicines-market
About Orion market research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, custom research reports, consulting and other research-based services.
Media contact:
Company name: Orion Market Research
Contact: Mr. Anurag Tiwari
Email: [email protected]
Contact number: +91 7803040404